(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ: ARCT) dropped 8.1% to $14.86 at 14:28 EST on Tuesday, after five sequential sessions in a row of gains. NASDAQ is dropping 2.41% to $11,247.29, following the last session’s downward trend. This seems, up to now, an all-around bearish trend trading session today.
Arcturus Therapeutics’s last close was $16.17, 75.12% below its 52-week high of $65.00.
Today’s last reported volume for Arcturus Therapeutics is 169000 which is 77.67% below its average volume of 756967.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 51.9% for the present quarter and a decline by 42.1% for the next. The company’s growth estimates for the current quarter and the next is 15.5% and 22.4%, respectively.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 158.9%, now sitting on 12.36M for the twelve trailing months.
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.69%, a negative 1.12%, and a positive 6.97%, respectively.
Arcturus Therapeutics’s highest amplitude of average volatility was 2.69% (last week), 6.27% (last month), and 6.97% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be oversold (<=20).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $14.86 at 14:28 EST, way under its 52-week high of $65.00 and way above its 52-week low of $11.70.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s value is way below its 50-day moving average of $18.56 and way below its 200-day moving average of $30.87.
More news about Arcturus Therapeutics (ARCT).